Chembio Diagn (CEMI) Tops Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts CEMI Hot Sheet
Price: $0.46 --0%
Financial Fact:
Research and development expenses: 2.26M
Today's EPS Names:
ORPB, ONEG, NDLS, More
Financial Fact:
Research and development expenses: 2.26M
Today's EPS Names:
ORPB, ONEG, NDLS, More
Join SI Premium – FREE
Chembio Diagn (NASDAQ: CEMI) reported Q2 EPS of $0.04, $0.01 better than the analyst estimate of $0.03. Revenue for the quarter came in at $6.08 million versus the consensus estimate of $6.36 million.
For earnings history and earnings-related data on Chembio Diagn (CEMI) click here.
For earnings history and earnings-related data on Chembio Diagn (CEMI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TPU-As-A-Service could boost Google’s 2028 profit by over 15%: Barclays
- Surgery Partners agrees to sell Idaho Falls hospitals for $1.15B
- Verizon secures $1B+ dark fiber deal with Google
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
